৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬





Quantity:
Products
Payment
Delivery
Depression
May be taken with or without food.
Oral\r\nDepression\r\nAdult: As hydrochloride: 25-75 mg daily in 3 divided doses, gradually increased in 25 mg increments at 1-2 wk intervals to 150 mg/day if necessary. Up to 225 mg/day in severely depressed patients.\r\nElderly: Initial: 25 mg daily. May increase slowly according to response to 50-75 mg daily if needed.
Safety and effecay not established
Preexisting CV insufficiency; epilepsy or lowered seizure threshold.
Maprotiline is a tetracyclic antidepressant pharmacologically similar to the tricyclic antidepressants. It's antidepressant effects appear to be due principally to inhibition of the re-uptake of noradrenaline at the neuronal membrane.
Urinary retention, prostatic hyperplasia, chronic constipation, untreated angle-closure glaucoma; hyperthyroidism; risk of suicide; may precipitate mania or psychotic symptoms; withdraw gradually; may impair ability to operate machinery. Pregnancy and lactation; elderly.\r\n\r\nLactation: avoid during breastfeeding
Common\r\nFatigue,Sedation,Lethargy,Weakness,Constipation,Dry mouth,Blurred vision\r\n\r\nLess Common\r\nAgitation,Anxiety,Headache,Insomnia,Nausea,Vomiting,Sweating\r\n\r\nInfrequent\r\nOrthostatic hypotension, ECG changes, tachycardia\r\nConfusion, EPS, dizziness, paresthesia, tinnitus\r\nRash,Incr LFTs,Sexual dysfunction\r\n\r\nRare\r\nSeizure,Agranulocytosis,Thrombocytopenia,Eosinophilia,Leukopenia,SIADH\r\n\r\nPotentially Fatal: Seizures
MAOIs. Increase in sedative effect with alcohol. Increased effect of antidiabetics. Maprotiline concentrations and toxicity increased by propranolol, risperidone. Risk of seizures increased with phenothiazines.
Depression
May be taken with or without food.
Oral\r\nDepression\r\nAdult: As hydrochloride: 25-75 mg daily in 3 divided doses, gradually increased in 25 mg increments at 1-2 wk intervals to 150 mg/day if necessary. Up to 225 mg/day in severely depressed patients.\r\nElderly: Initial: 25 mg daily. May increase slowly according to response to 50-75 mg daily if needed.
Safety and effecay not established
Preexisting CV insufficiency; epilepsy or lowered seizure threshold.
Maprotiline is a tetracyclic antidepressant pharmacologically similar to the tricyclic antidepressants. It's antidepressant effects appear to be due principally to inhibition of the re-uptake of noradrenaline at the neuronal membrane.
Urinary retention, prostatic hyperplasia, chronic constipation, untreated angle-closure glaucoma; hyperthyroidism; risk of suicide; may precipitate mania or psychotic symptoms; withdraw gradually; may impair ability to operate machinery. Pregnancy and lactation; elderly.\r\n\r\nLactation: avoid during breastfeeding
Common\r\nFatigue,Sedation,Lethargy,Weakness,Constipation,Dry mouth,Blurred vision\r\n\r\nLess Common\r\nAgitation,Anxiety,Headache,Insomnia,Nausea,Vomiting,Sweating\r\n\r\nInfrequent\r\nOrthostatic hypotension, ECG changes, tachycardia\r\nConfusion, EPS, dizziness, paresthesia, tinnitus\r\nRash,Incr LFTs,Sexual dysfunction\r\n\r\nRare\r\nSeizure,Agranulocytosis,Thrombocytopenia,Eosinophilia,Leukopenia,SIADH\r\n\r\nPotentially Fatal: Seizures
MAOIs. Increase in sedative effect with alcohol. Increased effect of antidiabetics. Maprotiline concentrations and toxicity increased by propranolol, risperidone. Risk of seizures increased with phenothiazines.





N/A
